SYVC

Synovics Pharmaceuticals OTCPK:SYVC Stock Report

Last Price

US$0.0001

Market Cap

US$3.6k

7D

0%

1Y

n/a

Updated

31 Oct, 2023

Data

Company Financials

Synovics Pharmaceuticals, Inc.

OTCPK:SYVC Stock Report

Market Cap: US$3.6k

SYVC Stock Overview

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States.

SYVC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Synovics Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Synovics Pharmaceuticals
Historical stock prices
Current Share PriceUS$0.0001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

SYVCUS PharmaceuticalsUS Market
7D0%-0.007%1.0%
1Yn/a25.3%31.2%

Return vs Industry: Insufficient data to determine how SYVC performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SYVC performed against the US Market.

Price Volatility

Is SYVC's price volatile compared to industry and market?
SYVC volatility
SYVC Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: SYVC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SYVC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1983n/aJyotindra Gange

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States.

Synovics Pharmaceuticals, Inc. Fundamentals Summary

How do Synovics Pharmaceuticals's earnings and revenue compare to its market cap?
SYVC fundamental statistics
Market capUS$3.65k
Earnings (TTM)-US$5.04m
Revenue (TTM)US$19.09m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYVC income statement (TTM)
RevenueUS$19.09m
Cost of RevenueUS$14.63m
Gross ProfitUS$4.47m
Other ExpensesUS$9.51m
Earnings-US$5.04m

Last Reported Earnings

Jul 31, 2009

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did SYVC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.